Literature DB >> 23301368

WHO/INRUD patient care and facility-specific drug use indicators at primary health care centres in Eastern province, Saudi Arabia.

A A El Mahalli1, O A M Akl, S F Al-Dawood, A A Al-Nehab, H A Al-Kubaish, S Al-Saeed, A A A Elkahky, A M A A Salem.   

Abstract

This study aimed to measure the performance of primary health care centres in Eastern province, Saudi Arabia, using the WHO/International Network of Rational Use of Drugs patient care and facility-specific drug use indicators. In a cross-sectional study, 10 health centres were selected using systematic random sampling. A total of 300 patients were interviewed while visiting the centre from January to March 2011 and 10 pharmacists from the same centres were interviewed. Average consultation time was 7.3 min (optimal > or = 30 min), percentage of drugs adequately labelled was 10% (optimal 100%) and patient's knowledge of correct dosage was 79.3% (optimal 100%). The percentage of key drugs in stock was only 59.2% (optimal 100%). An overall index of rational facility-specific drug use was calculated and applied to rank the health centres for benchmarking.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23301368     DOI: 10.26719/2012.18.11.1086

Source DB:  PubMed          Journal:  East Mediterr Health J        ISSN: 1020-3397            Impact factor:   1.628


  17 in total

1.  Prescribing Pattern of Antibiotics Using WHO Prescribing Indicators Among Inpatients in Ethiopia: A Need for Antibiotic Stewardship Program.

Authors:  Gebre Teklemariam Demoz; Gebremicheal Gebreslassie Kasahun; Kalay Hagazy; Gebremariam Woldu; Shishay Wahdey; Degena Bahrey Tadesse; Yirga Legesse Niriayo
Journal:  Infect Drug Resist       Date:  2020-08-11       Impact factor: 4.003

2.  Medication utilization pattern among outpatients during the Hajj mass gathering.

Authors:  Saber Yezli; Sabra Zaraa; Yara Yassin; Abdulaziz Mushi; Andy Stergachis; Anas Khan
Journal:  Saudi Pharm J       Date:  2020-08-05       Impact factor: 4.330

3.  Assessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan.

Authors:  Muhammad Atif; Muhammad Rehan Sarwar; Muhammad Azeem; Mubeen Naz; Salma Amir; Kashaf Nazir
Journal:  BMC Health Serv Res       Date:  2016-12-08       Impact factor: 2.655

4.  Assessment of drug use patterns in terms of the WHO patient-care and facility indicators at four hospitals in Southern Ethiopia: a cross-sectional study.

Authors:  Kassa Daka Gidebo; Temesgen Sidamo Summoro; Zewde Zema Kanche; Eskinder Wolka Woticha
Journal:  BMC Health Serv Res       Date:  2016-11-10       Impact factor: 2.655

5.  Examination of WHO/INRUD Core Drug Use Indicators at Public Primary Healthcare Centers in Kisii County, Kenya.

Authors:  Aggrey O Nyabuti; Faith A Okalebo; Eric M Guantai
Journal:  Adv Pharmacol Pharm Sci       Date:  2020-06-19

6.  The Impact of Longer Consultation Time: A Simulation-Based Approach.

Authors:  Abdulrahman M Jabour
Journal:  Appl Clin Inform       Date:  2020-12-23       Impact factor: 2.342

7.  Evaluation of Rational Use of Medicine Using WHO/INRUD Core Drug Use Indicators at Teda and Azezo Health Centers, Gondar Town, Northwest Ethiopia.

Authors:  Faisel Dula Sema; Esubalew Delie Asres; Belaynesh Dubale Wubeshet
Journal:  Integr Pharm Res Pract       Date:  2021-06-21

8.  Assessment of WHO/INRUD core drug use indicators in two tertiary care hospitals of Bahawalpur, Punjab, Pakistan.

Authors:  Muhammad Atif; Muhammad Rehan Sarwar; Muhammad Azeem; Danial Umer; Abdul Rauf; Arslan Rasool; Muhammad Ahsan; Shane Scahill
Journal:  J Pharm Policy Pract       Date:  2016-09-22

Review 9.  International variations in primary care physician consultation time: a systematic review of 67 countries.

Authors:  Greg Irving; Ana Luisa Neves; Hajira Dambha-Miller; Ai Oishi; Hiroko Tagashira; Anistasiya Verho; John Holden
Journal:  BMJ Open       Date:  2017-11-08       Impact factor: 2.692

10.  Indicators related to the rational use of medicines and its associated factors.

Authors:  Marina Guimarães Lima; Juliana Álvares; Augusto Afonso Guerra; Ediná Alves Costa; Ione Aquemi Guibu; Orlando Mario Soeiro; Silvana Nair Leite; Margô Gomes de Oliveira Karnikowski; Karen Sarmento Costa; Francisco de Assis Acurcio
Journal:  Rev Saude Publica       Date:  2017-11-13       Impact factor: 2.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.